The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

Scientists say the current COVID vaccine is effective against the Nimbus variant and is considered a “variant under ...

According to WHO, globally, this variant contributed to 23 per cent of global COVID-19 cases as of last month.

Amid growing concerns over the safety of COVID-19 vaccines, a significant lawsuit against prominent figures in the pharmaceutical industry and public health has taken a dramatic turn. Three new ...

The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

Memoirs rule in the latest list of bestselling local books.

DOJ filed the statement of interest in United States District Court for the case Children’s Health Defense et al. v. Washington Post et al., which lists among its defendants the BBC, Reuters, the ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

Germany's consensus-driven parliamentary system has entered a more rough-and-tumble period amid a rise of the political ...

Just five years after the coronavirus pandemic struck, another animal-borne disease is mutating and spreading across borders ...